Related Experiment Video

Updated: Jun 19, 2026

Minimal Invasive Surgical Procedure of Inducing Myocardial Infarction in Mice
09:05

Minimal Invasive Surgical Procedure of Inducing Myocardial Infarction in Mice

Published on: May 4, 2015

Receptor for advanced-glycation end products: key modulator of myocardial ischemic injury

Loredana G Bucciarelli1, Michiyo Kaneko, Radha Ananthakrishnan

  • 1Division of Surgical Science, Department of Surgery, Columbia University Medical Center, New York, NY 10032, USA.

Circulation
|March 1, 2006
PubMed
Abstract

Insights

The receptor for advanced-glycation end products (RAGE) plays a key role in heart damage after ischemia/reperfusion (I/R) injury. Blocking RAGE protects the heart from I/R injury and improves recovery.

Area of Science:

  • Cardiovascular Biology
  • Molecular Medicine
  • Cellular Injury Mechanisms

Background:

  • Reperfusion therapies are limited by pre-existing ischemic damage.
  • Understanding cardiac cell death mechanisms post-ischemia/reperfusion (I/R) is crucial for developing interventions.
  • The receptor for advanced-glycation end products (RAGE) is investigated for its role in myocardial I/R injury.

Purpose of the Study:

  • To test the hypothesis that RAGE is a key modulator of myocardial I/R injury.
  • To investigate the impact of RAGE on cardiac function and metabolism during I/R.
  • To explore the therapeutic potential of targeting RAGE in I/R injury.

Main Methods:

  • Assessed RAGE and ligand expression in ischemic rat hearts.
  • Administered soluble RAGE (sRAGE) as a pretreatment in rats.
  • Utilized RAGE-null mice to specifically evaluate RAGE's role in I/R.
  • Measured cardiac function, lactate dehydrogenase (LDH) release, and adenosine triphosphate (ATP) levels.
  • Analyzed inducible nitric oxide synthase (iNOS), nitric oxide, cyclic guanosine monophosphate (cGMP), and nitrotyrosine levels.

Main Results:

  • RAGE and its ligands were significantly upregulated in ischemic rat hearts.
  • sRAGE pretreatment reduced ischemic injury and improved myocardial function in rats.
  • RAGE-null mice exhibited significant protection against I/R injury, with improved cardiac function and ATP levels.
  • RAGE activation correlated with increased iNOS, nitric oxide, cGMP, and nitrotyrosine in both species.

Conclusions:

  • RAGE plays a critical role in mediating myocardial I/R injury.
  • Targeting the RAGE axis offers a potential therapeutic strategy for reducing I/R damage.
  • RAGE interaction with advanced-glycation end products impacts myocardial energy metabolism and function during I/R.

More Related Videos

Murine Myocardial Infarction Model using Permanent Ligation of Left Anterior Descending Coronary Artery08:38

Murine Myocardial Infarction Model using Permanent Ligation of Left Anterior Descending Coronary Artery

Published on: August 16, 2019

Coronary Progenitor Cells and Soluble Biomarkers in Cardiovascular Prognosis after Coronary Angioplasty10:03

Coronary Progenitor Cells and Soluble Biomarkers in Cardiovascular Prognosis after Coronary Angioplasty

Published on: January 28, 2020

Related Concept Videos

Ligand-Gated Ion Channel Receptor: Gating Mechanism01:30

Ligand-Gated Ion Channel Receptor: Gating Mechanism

Ligand-gated ion channels are transmembrane proteins that play a vital role in intercellular communication and functions of the nervous system. They allow the influx of ions across the membrane once the neurotransmitter binds, allowing the subsequent transmission of electrical excitation across the neurons. Other ligand-gated ion channels, like the γ-aminobutyric acid (GABA) receptor, permit anions like chloride into the cells on the binding of the GABA molecule. Their entry into the cell...
Transducer Mechanism: Enzyme-Linked Receptors01:27

Transducer Mechanism: Enzyme-Linked Receptors

Enzyme-linked receptors are cell-surface receptors acting as an enzyme or associating with an enzyme intracellularly. They make excellent drug targets. Drugs can bind to the extracellular ligand-binding domain or directly affect their enzymatic domain and alter their activity.
Major types that are helpful drug targets include:
Blood Studies for Cardiovascular System I: Cardiac Biomarkers01:20

Blood Studies for Cardiovascular System I: Cardiac Biomarkers

Cardiac biomarkers are enzymes, proteins, and hormones released into the blood when cardiac cells are injured. They are powerful tools for triaging.
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...
Acute Coronary Syndrome III: Diagnostic Studies01:30

Acute Coronary Syndrome III: Diagnostic Studies

Diagnosing acute coronary syndrome or ACS begins with a thorough patient history. Notable symptoms include central, crushing chest pain radiating to the left arm, neck, jaw, or back, along with shortness of breath, sweating (diaphoresis), nausea, vomiting, dizziness, and palpitations.It is crucial to note any history of cardiac illnesses and assess risk factors, including age, gender, smoking, hypertension, diabetes, hyperlipidemia, and a sedentary lifestyle.During physical examination, vital...